Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122873 · ClinicalTrials.gov registry record
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 125
- Enrollment target
NCT03122873: Completed study, sponsored by Mayo Clinic.
NCT03122873 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122873 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The study is designed to quantitate McArdle's sign, an increase in measurable weakness with neck flexion described in patients with multiple sclerosis, and to determine whether it is or is not specific for multiple sclerosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2016-02-01 |
| Est. Completion | 2017-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122873
The ClinicalTrials.gov registry entry for NCT03122873 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03122873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03122873 about?
NCT03122873 is a clinical study titled "Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis". The study is designed to quantitate McArdle's sign, an increase in measurable weakness with neck flexion described in patients with multiple sclerosis, and to determine whether it is or is not specific for multiple sclerosis.
What is the current status of trial NCT03122873?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2016-02-01. Estimated completion is 2017-06-30.
Who is sponsoring clinical trial NCT03122873?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.